Breathing and anxiety: Understanding the effect of serotonin re-uptake inhibitors on the possible miscommunication between brain and body in individuals with clinical levels of anxiety

niversity of Otago0 个研究点目标入组 105 人开始时间: 2020年9月24日最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•Both groups:
•Diagnosed with any clinically significant anxiety disorder AND prescribed with a course of an SSRI by their medical practitioner
•Male or female aged between 18 and 45 years
•Ability to provide written and informed consent
•Ability to adhere to the study protocol
•Exposure group only: Either have not started or be within the first 7 days of beginning their SSRI medication
•Control group only: Have been taking their SSRI medication consistently for at least 3 months

•Evidence of severe acute or chronic medical disorders, including a neurological disorder, current or past history of a severe brain injury or severe respiratory disorder e.g. severe asthma, chronic obstructive pulmonary disease etc.
•Past or current diagnoses of schizophrenia, bipolar disorder, drug addiction or psychosis
•Colour blindness
•Female patients who are pregnant or breastfeeding
•Current significant suicidal ideation
•Participants must be free of recreational drug and alcohol use at the time of testing

发起方